1187318-53-1

Basic information

• Product Name: methyl 3-bromo-5-fluoro-2-methylbenzoate
• Synonyms: methyl 3-bromo-5-fluoro-2-methylbenzoate;3-BROMO-5-FLUORO-2-METHYL-BENZOIC ACID METHYL ESTER
• CAS NO: 1187318-53-1
• Molecular Formula: C₉H₈BrFO₂
• Molecular Weight: 247.0610232
• EINECS: -0
• Mol File: 1187318-53-1.mol

Chemical Properties

• Boiling Point: 262.9±40.0 °C(Predicted)
• Appearance: /
• Density: 1.506±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: methyl 3-bromo-5-fluoro-2-methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-bromo-5-fluoro-2-methylbenzoate(1187318-53-1)
• EPA Substance Registry System: methyl 3-bromo-5-fluoro-2-methylbenzoate(1187318-53-1)

Safety Data

• Hazardous Substances Data: 1187318-53-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-bromo-5-fluoro-2-methylbenzoate is used as a chemical intermediate for the synthesis of new drugs. Its unique structure allows for the development of pharmaceutical compounds with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, methyl 3-bromo-5-fluoro-2-methylbenzoate is utilized as a precursor in the production of agricultural chemicals. Its chemical properties make it suitable for creating compounds that can be used in pest control and crop protection.
Used in Research and Development:
Methyl 3-bromo-5-fluoro-2-methylbenzoate is employed in research and development processes to explore its potential applications and to create new compounds with desired characteristics for various industries. Its versatility as a chemical intermediate makes it a valuable asset in scientific investigations.
It is crucial to handle methyl 3-bromo-5-fluoro-2-methylbenzoate with proper care and adhere to safety guidelines due to its potential hazards.

Upstream product

• 175278-29-2 5-fluoro-2-methylbenzoic acid methyl ester 
• 850462-64-5 5-fluoro-2-methyl-3-nitrobenzoic acid 
• 246877-31-6 3-amino-5-fluoro-2-methylbenzoic acid 
• 67-56-1 methanol 
• 1187318-52-0 3-bromo-5-fluoro-2-methylbenzoic acid 
• 33184-16-6 5-fluoro-2-methylbenzoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 1187318-54-2 methyl 3-bromo-2-(bromomethyl)-5-fluorobenzoate 
• 1255208-37-7 (3-bromo-5-fluoro-2-methyl-phenyl)methanol 
• 1187318-56-4 {[3-bromo-2-(bromomethyl)-5-fluorobenzyl]oxy}(tert-butyl)dimethylsilane 
• 1187318-55-3 [3-bromo-2-(bromomethyl)-5-fluorophenyl]methanol 

Relevant articles and documents

SUBSTITUTED ISOINDOLINONES

Substituted isoindolinones of Formula (I), methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat or ameliorate diseases, disorders, or conditions associated with protein malfunction, such as cancer, are provided.

Aromatic ring-containing compound and application thereof

The present invention discloses an aromatic ring-containing compound and an application thereof, and provides an aromatic ring-containing compound represented by formula I, and a pharmaceutically acceptable salt, a hydrate, a solvate, a metabolite, a ster

OXOINDOLINE DERIVATIVES AS PROTEIN FUNCTION MODULATORS

The present invention provides chimeric compounds of formula (II) that modulate protein function, to restore protein homeostasis, including cytokine, aiolos, and/or ikaros activity, TNF-alpha activity, CKl-alpha activity and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of protein-mediated diseases, disorders, and conditions, such as cytokine-mediated diseases, disorders, and conditions, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, organ transplant rejection, and cancer, are provided.

TRICYCLIC DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)

The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion